CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 11 enrolled
Drug / intervention
Varenicline +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04089982
NCT04089982Phase 4Completed
CompareCT.gov

Pilot Study on Varenicline in Light and Intermittent Smokers

Duke University·interventional·Posted Sep 16, 2019·Updated May 11, 2021

In Brief

A Phase 4 clinical trial evaluating Varenicline and Placebo oral tablet for Smoking Cessation and 2 related conditions. Completed, enrolled 11 participants across 1 site.

Detailed Summary

The goal of this study is to assess varenicline vs. placebo for its effect on decreasing cue reactivity in light and intermittent smokers.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSmoking Cessation, Smoking Behaviors, Smoking
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
2020202120222023202420252026
First PostedSep 16, 2019
Enrollment StartNov 4, 2019
Primary CompletionMar 1, 2020
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 6.8 years ago

Interventions

Vareniclinedrug

Chantix

Placebo oral tabletdrug

Placebo